Tag

United States Archives - Carey Danis & Lowe

Vaginal Mesh Slings Fail in about 3 Percent of Incontinence Surgeries

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Boston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsBoston Scientific Ordered to Release Defective Transvaginal Mesh DocumentsA new study finds that about 1 in 30 women who opt for vaginal mesh implants need to remove or replace the devices within 10 years.

Patients fared best when sling operations were done by surgeons who performed the greatest volumes of surgeries.

The Journal of American Medical Association notes that in the United States, an estimated one in 7 adult females will have operations for urinary stress incontinence during their lifetime.

Research has linked the slings to mesh erosions, fistulas and chronic pain in the pelvic area and legs. Repairing the damage caused by vaginal slings, involves repeat surgeries to remove or replace the implants.

More than 50,000 women in the US have entered into class action lawsuits to recoup compensation for injuries caused by the mesh.

Carey Danis & Lowe seeks justice for those who have been harmed by vaginal mesh.

If you have pain and suffering related to a vaginal mesh implant, our product liability attorneys will guide you through your legal options.

During a free legal consultation, one of our defective medical device lawyers will walk you through compensation eligibility, and if applicable, the process of filing a vaginal mesh sling lawsuit.

To find out more about filing a vaginal mesh lawsuit, contact Carey Danis & Lowe by phone at 800.721.2519, or by completing a confidential personal injury claim.

Carey Danis & Lowe Announces Launch of GMO Corn Seed Online Resource

By | Class Action, GMO, Uncategorized

Published January 7, 2015 by PR Web

St. Louis, Missouri (PRWEB) January 07, 2015

gI_118526_cdl-pr-122014-gmo-corn-seed-lawsuitsCarey Danis & Lowe is pleased to announce the launch of their GMO corn seed online resource for U.S. corn farmers. This online resource features up-to-date, valuable information on GMO corn seed lawsuits in the U.S.

Carey Danis & Lowe launched this online resource in December 2014.

Carey Danis & Lowe is a law firm with headquarters in St. Louis, and with additional offices in Illinois and Florida. The law firm specializes in class action lawsuits.

Carey Danis & Lowe recognized a need for an online resource serving U.S. corn farmers who claim to have suffered financially as a result of GMO corn seed. According to the team of class action lawyers at Carey Danis & Lowe, the purpose of the newly launched GMO corn seed online resource is to fill this need.

Furthermore, the GMO corn seed online resource establishes, in digital form, the dedication and reliability of Carey Danis & Lowe towards U.S. corn farmers, said the class action lawyers.

Legal Assistance for U.S. Corn Farmers

Carey Danis & Lowe is available to review legal options with U.S. corn farmers who claim lost revenue from GMO corn seeds. The law firm offers complimentary and thorough case evaluations.

Carey Danis & Lowe can be reached by phone at 800.721.2519.

About Carey Danis & Lowe

Carey Danis & Lowe is a plaintiff’s litigation firm based in St. Louis, Missouri with law offices across the United States in Illinois, Missouri, and Florida. Carey Danis & Lowe specializes in class action lawsuits. The Carey Danis & Lowe team is comprised of experienced attorneys working alongside knowledgeable and professional staff that includes medical doctors, nurses, and information technology specialists. Contact Carey Danis & Lowe at 800.721.2519 for more information about their legal services.

Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order

By | Class Action, Consumer protection, GMO, Uncategorized

Published December 23, 2014 on PR Web

St. Louis, Missouri (PRWEB) December 23, 2014

GMO Corn Seed LawsuitsGMO corn cases filed across the United States, and targeting Swiss biotechnology company, Syngenta, are in the process of being consolidated in a Kansas federal court for pretrial proceedings. The consolidated case is In Re: Syngenta AG MIR 162 Corn Litigation, MDL No. 2591 in the U.S. District Court for the District of Kansas.

Management of the Syngenta GMO corn multidistrict litigation (MDL) has been handed over to U.S. District Judge John W. Lungstrum.*
As a Missouri law firm specializing in class action lawsuits, and currently representing U.S. corn farmers who claim to have suffered financially from Syngenta’s genetically-modified corn seed, Agrisure Viptera, or MIR 162, the team at Carey Danis & Lowe remains abreast of news that impacts U.S. corn farmers.

Carey Danis & Lowe believes that the Judicial Panel on Multidistrict Litigation (JPML) made a sound decision in ordering Syngenta GMO corn lawsuits to be centralized in one court. In the JPML’s transfer order, a reason given for ordering the centralization is to avoid redundant research and evidence gathering, the possibility of varying pretrial rulings, and overuse of defendant and plaintiff resources.

In all, the centralization of the Syngenta lawsuits will lead to an organized and efficient legal process, which is best for all parties involved, say Carey Danis & Lowe class action attorneys.

Legal Assistance for U.S. Corn Farmers & Exporters

As the St. Louis law firm currently represents U.S. corn farmers in cases involving claims against Syngenta, Carey Danis & Lowe is available to review legal options and compensation eligibility with U.S. corn farmers and exporters who claim lost revenue from Syngenta’s commercialization of the genetically-modified corn seed, Agrisure Viptera.

Carey Danis & Lowe can be reached by phone at 800.721.2519.

——————————————

About Carey Danis & Lowe

Carey Danis & Lowe is a plaintiff’s litigation firm based in St. Louis, Missouri with law offices across the United States in Illinois, Missouri, and Florida. Carey Danis & Lowe specializes in class action lawsuits. The Carey Danis & Lowe team is comprised of experienced attorneys working alongside knowledgeable and professional staff that includes medical doctors, nurses, and information technology specialists. Contact Carey Danis & Lowe at 800.721.2519 for more information about their legal services.

 

Source
United States Judicial Panel on Multidistrict Litigation, “In Re: Syngenta AG MIR 162 Corn Litigation, Transfer Order”, December 11, 2014: http://bit.ly/jpml-syngenta-transfer-order

Carey Danis & Lowe Weighs in on Testosterone Gel Safety

By | Pharmaceutical litigation, Testosterone, Uncategorized

St. Louis, Missouri (PRWEB) November 25, 2014

testosteroneAs a personal injury law firm with a focus on defective drug law, Carey Danis & Lowe have remained abreast of the news circulating on the topic of testosterone gel and testosterone-replacement therapy as they relate to patient health and safety. Testosterone gels have been placed under increased scrutiny over the past year, in large part due to a study published in the Journal of the American Medical Association (JAMA) in November 2013 whose findings showed an increase in the risk of heart attack and stroke in study participants who used testosterone.

Carey Danis & Lowe contends that, perhaps in response to the JAMA study, the Food and Drug Administration (FDA) recently made steps to address testosterone gel safety through appointing an advisory panel. This special panel of experts released their recommendations to the FDA in September 2014.

According to an article published by the Wall Street Journal in late October 2014, the panel recommended that the FDA complete two actions, the first to order drug makers to conduct studies on their particular testosterone products as they relate to cardiovascular health, and the second, to update testosterone product labeling to reflect the reality that extensive research does not exist validating the safety of testosterone products to treat low testosterone.*

The recommendations of the FDA panel introduce the right course of action, say Carey Danis & Lowe, defective drug lawyers. It is important to test testosterone gel and other testosterone products to better understand their impact on heart health. Furthermore, updating the product labeling is vital in providing healthcare providers and patients with the most up-to-date information on the safety of testosterone products, so that they can make informed health decisions.

Legal Assistance for Alleged Defective Drug Injuries

In addition to staying current on the FDA’s handling of testosterone gel, the legal team and medical professionals at Carey Danis & Lowe are also following the testosterone gel litigation taking place in a federal court in Illinois (U.S. District Court for the Northern District of Illinois, In re: Testosterone Replacement Therapy Product Liability Litigation, MDL no. 2545). As the St. Louis law firm provides legal assistance and representation to individuals who claim to have been injured by testosterone gel, Carey Danis & Lowe delivers their expert analysis on timely topics for the benefit of anyone interested in defective drug law and news.

Carey Danis & Lowe is available to review legal options, compensation eligibility, and health concerns with those who claim injury from testosterone gel products.
Carey Danis & Lowe can be reached by phone at 800.721.2519.

About Carey Danis & Lowe

Carey Danis & Lowe is a plaintiff’s litigation firm based in St. Louis, Missouri with law offices across the United States in Illinois, Missouri, and Florida. Carey Danis & Lowe specializes in defective drug and pharmaceutical litigation and class action lawsuits. The Carey Danis & Lowe team is comprised of experienced attorneys working alongside knowledgeable and professional staff that includes medical doctors, nurses, and information technology specialists. Contact Carey Danis & Lowe at 800.721.2519 for more information about our legal services.

 

Source
Wall Street Journal, “In Men’s Fight Against Aging, How Much Risk to Take?”, Melinda Beck, October 27, 2014: http://bit.ly/wsj-testosterone-replacement-therapy

Vaginal Mesh Update: Jury Decides Boston Scientific Lawsuit

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

boston_scientifi_transvaginal_mesh_lawsuitThe latest transvaginal mesh lawsuit update involves the jury having ruled in the second Boston Scientific transvaginal mesh lawsuit to go to trial. The lawsuit was being heard in a state court in Massachusetts, and involved the plaintiff, Maria Cardenas.

According to Bloomberg, Cardenas filed her lawsuit against Boston Scientific after sustaining injuries from the Obtryx sling, which Cardenas received to treat stress urinary incontinence (SUI).

Cardenas claimed that the Obtryx sling caused her such severe pain that she had to undergo surgery to have the medical device removed.

After 17 hours, the jury decided that the Obtryx sling is not a defectively designed product. In addition, they concluded that Boston Scientific did provide sufficient warning about the risks involved with use of their device.

Even though this particular jury ruled in favor of the device maker, the fact remains that thousands of women have been injured by transvaginal mesh and bladder slings. After extensive investigation into individual transvaginal mesh injury cases, it is clear to the defective medical device lawyers at Carey Danis & Lowe that these kinds of products pose a significant threat to patient health and safety.

Carey Danis & Lowe Represents Transvaginal Mesh Victims

A St. Louis law firm, Carey Danis & Lowe represents women in transvaginal mesh lawsuits across the United States. In working closely with each of our clients, we have come to understand the depth of pain and suffering caused by defective medical products. If you have sustained injuries from transvaginal mesh or a bladder sling, we encourage you to begin exploring your legal options today with Carey Danis & Lowe. Our lawyers are ready to assist you in holding accountable the manufacturers behind these defective medical devices.

Share your transvaginal mesh story with Carey Danis & Lowe today by calling 800.721.2519, or by submitting a personal injury claim form. Our law firm offers free case evaluations.

We look forward to working with you.

 

Reports Show Decline in Yaz Sales

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuitIn a recent financial report, Bayer, the pharmaceutical company behind the controversial contraceptive drug Yaz, published information showing that Yaz sales have been on the decline. According to Bayer’s report released in late July 2014, sales of Yaz have seen a significant drop when comparing the second quarter of 2013 to that of 2014.

Yaz sales brought in $250 million for Bayer in the second quarter of 2013, but only $191 million in the same quarter of 2014.

This sales decline may be related to the thousands of Yaz lawsuits that have been filed across the United States.

Also in their quarter two report is information on their $1.8 billion Yaz settlement.

Carey Danis & Lowe Represents Yaz Victims

Carey Danis & Lowe is a St. Louis law firm with highly-skilled lawyers committed to building strong cases that deliver compensation packages for our clients. Our personal injury lawyers are currently accepting Yaz, Yasmin, and Ocella cases.

If you or someone you love has been injured by Yaz, Yasmin, or Ocella, we encourage you to review your legal options and compensation eligibility with one of our lawyers today during a free initial case evaluation.

Share your Yaz story with Carey Danis & Lowe by calling 800.721.2519, or by completing a confidential personal injury claim form. We look forward to representing you.

Yaz Litigation Update: $1.8 Billion Yaz Settlement

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuitThe manufacturer of the ill-reputed contraceptive drug Yaz released a quarterly report in July that highlighted current Yaz and Yasmin litigation. According to Bayer’s report, there are around 5,000 Yaz and Yasmin lawsuits pending in the United States. In addition, Bayer reported that they arrived at a settlement agreement in early July 2014 that would affect nearly 9,000 lawsuits.

The settlement amount is for $1.8 billion. Under this particular Yaz settlement, only those cases involving venous thromboembolism, or the formation of blood clots, qualify to be considered for compensation.

Yaz & Blood Clots

Yaz and Yasmin, and the generic alternative, Ocella, have all gained the reputation of causing serious health complications, among them blood clots. Yaz, Yasmin, and Ocella contain a hormone called drospirenone which has been connected to an increased risk in the formation of blood clots.

Carey Danis & Lowe Represents Yaz Victims

Carey Danis & Lowe is a St. Louis law firm that provides expert legal representation to victims in defective drug litigation. Our attorneys are currently representing victims of Yaz, Yasmin, and Ocella, and are accepting cases.

If you or someone you love has been injured by Yaz, Yasmin, or Ocella, Carey Danis & Lowe encourages you to evaluate your options and compensation eligibility with us today in a free legal consultation.

Share your Yaz story with Carey Danis & Lowe today. We are available to listen to you. Call our law firm at 800.721.2519, or contact us by submitting a confidential personal injury claim form.

Carey Danis & Lowe Lawyers Review Potential Impact of Transvaginal Mesh Settlement

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Published November 7, 2013 by PR Web

St. Louis, MO (PRWEB) November 07, 2013

gI_117818_cdl-pr-102013-transvaginal-meshCarey Danis & Lowe transvaginal mesh lawyers believe that settlement discussions purported to be underway in the U.S. District Court for the Southern District of West Virginia involving five transvaginal mesh manufacturers could have the potential to accelerate the legal process for all parties, and most especially for individuals who claim injury from mesh devices. Furthermore, these settlement discussions could have a ripple effect in regards to the future handling of transvaginal mesh lawsuits.

As a national law firm providing legal counsel to victims of defective medical devices, Carey Danis & Lowe has a vested interest in seeing how the settlement discussions pan out, and if they do, how the settlement itself will be structured, especially in light of how many lawsuits are targeted at the five mesh manufacturers.

According to Bloomberg, there are over 30,000 lawsuits pending in the five multidistrict litigations (MDLs) in the federal court in West Virginia.*

The settlement discussions involve lawsuits that have been consolidated into a federal court in West Virginia. The cases are In Re: C. R. Bard Inc., Pelvic Repair System Products Liability Litigation MDL No. 2187; In Re: American Medical Systems, Inc., Pelvic Repair System Products Liability Litigation MDL No. 2325; In Re: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation MDL No. 2326; In Re: Coloplast Corp., Pelvic Repair Support Systems Products Liability Litigation MDL No. 2387; and In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation MDL No. 2440.

According to the team of transvaginal mesh lawyers at Carey Danis & Lowe, though settlement discussions could eliminate the bellwether trial process, which, although useful, sometimes has a protracted pretrial time line, such discussions will not resolve cases immediately. Due to the sheer number of transvaginal mesh lawsuits consolidated in the West Virginia federal court, it is important for plaintiffs to wait patiently for justice and resolution to run its course.

The St. Louis class action attorneys at Carey Danis & Lowe will continue to closely follow the proceedings and discussions in West Virginia in order to keep abreast of the latest information.

Carey Danis & Lowe is currently investigating transvaginal mesh cases, and invites individuals who believe their injuries stem from a defective medical device to reach out to the law firm for a gratis legal evaluation. For more information about legal services provided by Carey Danis & Lowe, call 800-721-2519.

About Carey Danis & Lowe

Carey Danis & Lowe is a plaintiff’s litigation firm based in St. Louis, Missouri with law offices across the United States in Illinois, Missouri, and Florida. Carey Danis & Lowe specializes in defective drug and pharmaceutical litigation and class action lawsuits. The Carey Danis & Lowe team is comprised of experienced attorneys working alongside knowledgeable and professional staff that includes medical doctors, nurses, and information technology specialists. Contact Carey Danis & Lowe at 800-721-2519 for more information about our legal services.

Source

Carey Danis & Lowe Investigates Bard LifeStent Cases After FDA Class 1 Recall

By | Defective Medical Device litigation, Uncategorized

Published October 30, 2013 by PR Web

St. Louis, Missouri (PRWEB) October 30, 2013

bard_lifestent_solo_vascular_stent_lawsuit_fda_recallThe defective medical device attorneys at Carey Danis & Lowe are currently investigating Bard LifeStent cases following an October 18, 2013 recall announcement made by the U.S. Food and Drug Administration (FDA). As a national law firm representing victims of defective medical devices, Carey Danis & Lowe provides legal assistance to individuals who have experienced injuries from faulty medical products that have been recalled by the FDA.

In mid-October, the FDA announced a class 1 recall of the Bard LifeStent Solo Vascular Stent over faulty deployment.* The Bard LifeStent solo vascular stent, a mesh tube implanted into a blood vessel to treat lesions, is known to deploy partially and with difficulty, and in some cases, the stent entirely fails to deploy.

These deployment problems place patient health and safety at risk. According to the FDA, patients with inadequately deployed Bard LifeStent devices have experienced bleeding, limb loss, heart attacks, stroke, and death. Furthermore, patients have often undergone surgical operations to repair and replace the defective stent to avoid future health complications.

Though the FDA has taken action to recall the Bard LifeStent device due to life-threatening adverse events, claims targeted at Bard’s medical device have not yet been heard in a court of law at the time of writing.

The FDA class 1 recall concerns stents manufactured by Bard between November 2011 to June 2012.

Carey Danis & Lowe is currently investigating Bard LifeStent cases, and invites individuals who believe their injuries stem from defective stent deployment to reach out to the law firm for a gratis legal evaluation. For more information about legal services provided by Carey Danis & Lowe, call 800-721-2519.

About Carey Danis & Lowe

Carey Danis & Lowe is a plaintiff’s litigation firm based in St. Louis, Missouri with law offices across the United States in Illinois, Missouri, and Florida. Carey Danis & Lowe specializes in defective drug and pharmaceutical litigation and class action lawsuits. The Carey Danis & Lowe team is comprised of experienced attorneys working alongside knowledgeable and professional staff that includes medical doctors, nurses, and information technology specialists. Contact Carey Danis & Lowe at 800-721-2519 for more information about our legal services.

Source
*U.S. Food and Drug Administration, Bard LifeStent Solo Vascular Stent: Class 1 Recall – Failure to Deploy:http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm371415.htm

Carey Danis & Lowe Encouraged by C. R. Bard Settlement in New Jersey Transvaginal Mesh Lawsuit

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

St. Louis, Missouri (PRWEB) September 30, 2013

gI_58887_TVMThe law firm of Carey Danis & Lowe continues to closely follow transvaginal mesh lawsuit news across the country. As a national law firm representing women who allege that transvaginal mesh caused them harm and injury, Carey Danis & Lowe transvaginal mesh lawyers were encouraged by the outcome of a lawsuit in New Jersey involving the medical device manufacturer, C. R. Bard.

The transvaginal mesh lawsuit was scheduled to go to trial in late September in the Superior Court of New Jersey in Atlantic City, according to Bloomberg.* However, before proceedings could commence, C. R. Bard reached a settlement agreement with the plaintiff. The settlement amount has not been made public.

The lawsuit, Virgil v. C. R. Bard Inc., ATL-L6917-10, involves a Colorado woman, Melanie Virgil, who received an implant of the C. R. Bard Avaulta Plus mesh. In her lawsuit, Virgil claims that the C. R. Bard mesh severely impacted her health, requiring several surgical operations.

In past lawsuits that went to trial, C. R. Bard was ordered to pay $5.5 million in a California case, and $2 million in a federal case in West Virginia.

Transvaginal mesh lawsuits have been consolidated into the U.S. District Court for the Southern District of West Virginia. The C. R. Bard multidistrict litigation (MDL) is In re: C. R. Bard, Inc. Pelvic Repair System Products Liability Litigation MDL No. 2187. C. R. Bard faces approximately 4,600 cases in the West Virginia MDL.

Carey Danis & Lowe lawyers are currently working on transvaginal mesh cases, and are offering legal evaluations to parties that claim injury. For more information about legal services provided by the attorneys at Carey Danis & Lowe, call 800-721-2519.

―——

ABOUT CAREY DANIS & LOWE

Carey Danis & Lowe is a plaintiff’s litigation firm based in St. Louis, Missouri with law offices across the United States in Illinois, Missouri, and Florida. Carey Danis & Lowe specializes in defective drug and pharmaceutical litigation and class action lawsuits. The Carey Danis & Lowe team is comprised of experienced attorneys working alongside knowledgeable and professional staff that includes medical doctors, nurses, and information technology specialists. Contact Carey Danis & Lowe at 800-721-2519 for more information.